2-201487868-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001168221.2(C2CD6):c.5207T>A(p.Met1736Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001168221.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C2CD6 | NM_001168221.2 | c.5207T>A | p.Met1736Lys | missense_variant | 16/16 | ENST00000439140.6 | NP_001161693.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C2CD6 | ENST00000439140.6 | c.5207T>A | p.Met1736Lys | missense_variant | 16/16 | 1 | NM_001168221.2 | ENSP00000409937.1 | ||
C2CD6 | ENST00000286195.7 | c.1616T>A | p.Met539Lys | missense_variant | 15/15 | 1 | ENSP00000286195.3 | |||
C2CD6 | ENST00000439802.5 | c.*84T>A | 3_prime_UTR_variant | 13/13 | 2 | ENSP00000400672.1 | ||||
C2CD6 | ENST00000482942.1 | n.135T>A | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000800 AC: 2AN: 250048Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135034
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1459900Hom.: 0 Cov.: 30 AF XY: 0.00000551 AC XY: 4AN XY: 726222
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2022 | The c.5207T>A (p.M1736K) alteration is located in exon 16 (coding exon 16) of the ALS2CR11 gene. This alteration results from a T to A substitution at nucleotide position 5207, causing the methionine (M) at amino acid position 1736 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at